CellaVision saw the highest growth of 0.99% in patent filings and no patents were granted in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of CellaVision‘s patent filings and grants. Buy the databook here.
CellaVision has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 50% filings and 100% grants. The European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where CellaVision is filings its patents. Among the top granted patent authorities, CellaVision has 100% of its grants in European Patent Office(EPO).
Olympus and Carl Zeiss Stiftung could be the strongest competitors for CellaVision
Patents related to machine learning and industrial automation lead CellaVision's portfolio
CellaVision has the highest number of patents in machine learning followed by, industrial automation. For machine learning, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Digital signal processors(dsp) related patents lead CellaVision portfolio followed by image management
CellaVision has highest number of patents in digital signal processors(dsp) followed by image management.
For comprehensive analysis of CellaVision's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.